Scientists develop and monitor two approaches to fix blood vessel abnormalities that make tumors difficult to treat
Combining the approaches may be a powerful anti-cancer strategy.
Clinical Research: Renal and Mesenteric Artery Disease
Contact the Fireman Vascular Center
Reach us by phone or online to request an appointment, find a provider and more.
At the Massachusetts General Hospital Fireman Vascular Center, our world-renowned research advances patient care in the field of renal and mesenteric artery disease.
Advancing Vascular Care
Clinical research in the Renal and Mesenteric Artery Disease Program at the Massachusetts General Hospital Fireman Vascular Center combines leading research with patient care to develop innovative options to treat renal and mesenteric artery disease.
View a sample of our clinical research below.
ARTISAN: iCAST™ RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients with Resistant Hypertension
- Description of study: The primary objective of the ARTISAN trial is to evaluate the safety and efficacy of the iCAST™ RX Stent System for the treatment of subjects with resistant hypertension associated with de novo atherosclerotic renal artery disease.
- Study type: Clinical Trial
- Principal Investigator: Douglas Drachman, MD
#1 Research Hospital in America
Mass General is the #1 hospital in New England based U.S. News & World Report Best Hospitals for 2022-2023.
Fireman Vascular Center Advances in Motion
Information for health care professionals about the latest cardiovascular breakthroughs, research and clinical advances from Mass General.
Related News and Articles
- Patient Story
- Feb | 10 | 2021
Overcoming All Odds for A New Kidney
When Ann Foti learned that she could become a living donor for her husband, Gino, she was determined to donate her kidney to him; however, because of complications with Gino’s condition and the onset of the COVID-19 pandemic, their journey toward transplantation surgery was far from simple.
- Press Release
- Jul | 16 | 2020
Mass General Hospital study finds no relationship between blood type and severity of COVID-19
Blood type is not associated with a severe worsening of symptoms in people who have tested positive for COVID-19, researchers from Massachusetts General Hospital (MGH) have reported, dispelling previous reports that suggested a correlation between certain blood type and COVID-19
- Patient Education
- May | 5 | 2020
Q&A: What You Should Know About Stroke Risk and COVID-19
In this Q&A, Aneesh Singhal, MD, vice chair of the Department of Neurology, describes the risk of clotting disorders among COVID-19 patients, the treatment options available, how patients can prevent stroke and what to do if they experience symptoms.
1of
4
Contact the Fireman Vascular Center
Reach us by phone or online to request an appointment, find a provider and more.